Arrowhead Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.About ARWR
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.
ARWR Key Statistics
Stock Snapshot
With a market cap of 9.1B, Arrowhead Pharmaceuticals(ARWR) trades at $66.97. The stock has a price-to-earnings ratio of -1024.26.
As of 2025-12-10, Arrowhead Pharmaceuticals(ARWR) stock has fluctuated between $65.93 and $68.82. The current price stands at $66.97, placing the stock +1.6% above today's low and -2.7% off the high.
Arrowhead Pharmaceuticals(ARWR) shares are trading with a volume of 1.47M, against a daily average of 4.06M.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $71.50 and a 52-week low of $9.57.
In the last year, Arrowhead Pharmaceuticals(ARWR) shares hit a 52-week high of $71.50 and a 52-week low of $9.57.
ARWR News
New insider activity at Arrowhead Pharmaceuticals ( (ARWR) ) has taken place on December 9, 2025. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for...
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Arrowhead Pharmaceuticals today and set a price target of $85.00. TipRanks Cyber Monday Sale...
Arrowhead Pharmaceuticals recently reported that the FDA granted Breakthrough Therapy designation to its investigational RNAi drug plozasiran as an add-on to di...
Analyst ratings
64%
of 14 ratingsMore ARWR News
In a report released today, Michael Ulz from Morgan Stanley maintained a Hold rating on Arrowhead Pharmaceuticals, with a price target of $48.00. TipRanks Cyber...
Arrowhead Pharmaceuticals (ARWR) just got a meaningful regulatory boost, with the FDA granting Breakthrough Therapy designation to its triglyceride lowering dru...